Americas Gold and Silver Corporation (TSX: USA) (NYSE American: USAS) ("Americas" or the "Company") a growing North American precious metals and antimony producer, is pleased to announce the discovery ...

The MAD portion of the study enrolled a total of 76 participants.

Trevi Therapeutics (TRVI) advances Haduvio for IPF cough/RCC; Phase 2 IPF data strong, but funding, safety & opioid-label ...

Altimmune, Inc. (NASDAQ:ALT) Q4 2025 Earnings Call Transcript March 5, 2026 Altimmune, Inc. misses on earnings expectations. Reported EPS is $-0.27191 EPS, expectations were $-0.25. Operator: Good ...

Frequent late-night hunger may reflect hormonal shifts, sleep disruption or metabolic conditions rather than poor ...

Kiosk-based cannabis access for seniors can be a positive development only if it is embedded within a medically supervised, ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 2:00 PM EDTCompany ParticipantsAdam Steensberg - President ...

Medication can significantly improve the ability to initiate tasks, sustain attention, and complete responsibilities”— ...

Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...

AbbVie (NYSE: ABBV) today announced positive topline results1 from the multiple ascending dose (MAD) part of its Phase 1 study evaluating the safety, tolerability, pharmacokinetics (PK), and ...

Copperfield lambasts the additional workload that the 2026/27 contract's new QOF requirements will dump onto GPs ...

Omada Health (NASDAQ:OMDA) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for standing by. Welcome to the Omada Health Fourth Quarter 2025 Earnings Conference Call.